Strategy advice from someone who has done the work
Talon Group Consulting is a Boston-based strategy advisory for senior life science leaders. We help leadership teams decide where AI and technology belong in their strategies, portfolios and roadmaps, and which bets to fund, reshape or stop.
Aditi Sharma
Life Science Strategy Advisor
Aditi Sharma founded Talon Group Consulting to give senior life science leaders a clear answer to a hard question: where does technology belong in the decision in front of them, and where doesn't it?
For more than a decade, she has advised pharma, biotech, medtech and life science tools companies on growth and launch strategy, digital health and partnership choices, and AI and technology investments inside regulated functions. Her clients have included teams at Merck, Moderna, Abbott, Danaher, Pfizer, AstraZeneca, GSK and Bristol Myers Squibb.
Before founding the firm, she was a Senior Consultant at North Highland and a Business Analyst at Accenture. She holds graduate degrees in biotechnology from the University of Pennsylvania and in biomedical engineering from Carnegie Mellon, so she reads the science, the data and the business case with equal care.
She writes Talon Catalyst, an executive newsletter on where technology changes strategy in the life sciences. She also serves as President of Corporate Relations for the New England chapter of the Healthcare Businesswomen's Association.
Where her judgment comes from
Experience across the decisions our clients bring us, from the commercial side of the business to the regulated functions where technology choices carry the most risk.
Growth and launch strategy
Franchise growth options, market and indication prioritization, and launch sequencing across global markets.
AI and technology investment
Deciding which AI, automation and data investments to fund, stop or sequence, and testing vendor claims against real performance.
Regulatory, clinical and R&D operations
Operating model, governance and capability decisions in regulatory, safety, clinical and R&D functions.
Partnerships and acquisitions
Digital health partner assessment, build, buy or partner choices, and customer evidence for acquisition growth cases.
Qualifications
- Master's in Biotechnology, University of Pennsylvania, with healthcare management coursework at the Wharton School
- MS in Biomedical Engineering, Carnegie Mellon University
- BS in Biological Engineering and BS in Biological Sciences, Louisiana State University
Organizations she has worked with
Global pharma, biotech, medtech and life science tools leaders.
Facing a consequential strategy decision?
Bring the decision in front of you. We will help you frame it, test it and decide where technology belongs in the answer.